VAI researcher wins national award
Van Andel Institute’s founding research director has been awarded the Fellowship Award in biological science from the American Association for the Advancement of Science.
Dr. George Vande Woude received the award, which is given annually by the AAAS to a select number of scientists, recognizing them for their meritorious efforts to advance science or its applications.
The AAAS is a nonprofit with the mission of promoting cooperation among scientists, encouraging scientific responsibility and supporting education and outreach initiatives that directly impact human health.
Vande Woude said he’s “very pleased” to accept the Fellowship Award.
“It is truly an honor,” he said.
Vande Woude is responsible for discovering the human MET oncogene, a groundbreaking therapeutic target used in personalized therapies for many virulent cancers.
He is currently involved in ongoing research with the Breast Cancer Research Foundation.
Vande Woude and Dr. Ilan Tsarfaty, of Tel Aviv University, are working to determine the mechanisms of MET that contribute to breast cancer metastasis and therapy resistance, according to the BCRF website.
Vande Woude has been recognized throughout his career for his contributions to medicine.
In 1999, Vande Woude was appointed as the first director of Van Andel Research Institute.
In 2009, Vande Woude stepped down as director and assumed the title of distinguished scientific fellow, retaining his role as head of the Laboratory of Molecular Oncology.